Bridgewater Just Sold Salesforce: A Patient-Stock Debate
Bridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Glide paths in target date funds describe how asset allocations shift automatically as retirement nears, balancing growth and risk over time. This intro explains the idea and why it matters for planning.
25,488 articlesBridgewater Associates exits its Salesforce stake, prompting a broader discussion on how patient capital should value...
Mortgage rates remain above 6.7% amid persistent inflation concerns and a solid jobs market, with housing demand show...
Adobe's 2026 earnings trajectory hinges on subscription momentum, AI-enabled products, and disciplined costs. This gu...
A global survey of 6,000 professionals across 25 countries finds accounting may look completely different by 2040, dr...
SpaceX shares declined about 7% after the Federal Reserve kept rates steady, ending a brief three-day rally since its...
When a legend passes, we glimpse more than fame. This piece examines clive davis's money-minded approach to nurturing...
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
Is IonQ stock overvalued right? This in-depth guide breaks down the technology, market timing, and financials to help...
An investment idea rarely makes headlines for decades, yet one ETF has repeatedly outpaced the S&P 500. Learn how equ...
Anthropic’s looming IPO could reshape AI investing. With a private valuation near the hundreds of billions and big te...
GM is navigating a tepid U.S. EV market, yet the company is pivoting toward energy storage and software. This article...
Dell Technologies has surged on AI demand, pushing year-to-date gains toward 230% as investors bet the hardware giant...